Skip to main content
SpringerLink
Log in

Non-recent history of influenza pandemics, vaccines, and adjuvants

  • Chapter
Book cover Influenza Vaccines for the Future

Part of the book series: Birkhäuser Advances in Infectious Diseases ((BAID))

Abstract

Mankind has been affected by influenza epidemics and pandemics for many centuries. As for many others infectious diseases, measures to reduce the heavy burden of this disease through prevention were first developed during the 20th century. The purpose of this chapter is to describe the non-recent history of influenza, including the origin of the disease, the pandemics and the epidemics. Moreover, we also discuss the first attempts to develop safe and efficacious vaccines, including the negative experience with the swine influenza vaccination and the numerous attempts to improve the efficacy of influenza vaccines using adjuvants carried out since the 1950s.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ghendon Y (1994) Introduction to pandemic influenza through history. Eur J Epidemiol 10: 451–453

    Article  PubMed  CAS  Google Scholar 

  2. Fukuda K, Levandowski RA, Bridges CB, Cox NJ (2004) Inactivated influenza vaccines. In: SA Plotkin, WA Orenstein (eds): Vaccines, 4th edn. Saunders, Philadelphia, 339–370

    Google Scholar 

  3. Potter CW (1998) Chronicle of influenza pandemics. In: KG Nicholson, RF Webster, AJ Hay (eds): Textbook of Influenza. Blackwell Science, Oxford, 3–18

    Google Scholar 

  4. Hirsch A (1883) Handbook of Geographical and Historical Pathology. New Sydenham Society, London

    Google Scholar 

  5. Pyle GF (1986) The Diffusion of Influenza: Patterns and Paradigms. Rowan & Littlefield, New Jersey

    Google Scholar 

  6. Beveridge WIB (1991) The chronicle of influenza epidemics. History Philos Life Sci 13: 223–235

    CAS  Google Scholar 

  7. Potter CW (2001) A history of influenza. J Appl Microbiol 91: 572–579

    Article  PubMed  CAS  Google Scholar 

  8. Finkler D (1899) Influenza in twentieth century practice. In: TL Shipman (ed): An International Encyclopaedia of Modern Medical Science. Sampson Law & Marston, London, abstract 12, 21–32

    Google Scholar 

  9. Patterson KD (1987) Pandemic Influenza 1700-1900; A Study in Historical Epidemiology. Rowman & Littlefield, New Jersey

    Google Scholar 

  10. Brown MW (1932) Early epidemics of influenza in America. J Med Rec 135: 449–451

    Google Scholar 

  11. Beveridge WIB (1977) Influenza: The Last Great Plague. Heinemann, London

    Google Scholar 

  12. Pyle GF, Patterson K (1984) Influenza diffusion in European history: Patterns and paradigms. Ecol Dis 2: 173–184

    Google Scholar 

  13. Thompson ES (1890) Influenza. Pervical, London

    Google Scholar 

  14. Burnet FM, Clark E (1942) Influenza. A survey of the last 50 years in the light of modern work on the virus of epidemic influenza. Monogr Walter Eliza Hall Inst Res Pathol Med 69–99

    Google Scholar 

  15. Shope RE (1931) Swine influenza: Experimental transmission and pathology. J Exp Med 54: 349–359

    Article  Google Scholar 

  16. Hope-Simpson R (1978) Sunspots and flu: A correlation. Nature 275: 86

    Article  Google Scholar 

  17. Francis T Jr, Magill TP (1937) The antibody response of human subjects vaccinated with the virus of human influenza. J Exp Med 65: 251–259

    Article  Google Scholar 

  18. Francis T Jr (1945) The development of the 1943 vaccination study of the commission on influenza. Am J Hygiene 42: 1–11

    Google Scholar 

  19. Francis T Jr, Salk JE, Pearson HE, Brown PN (1945) Protective effect of vaccination against induced influenza A. J Clin Invest 24: 536–546

    Article  PubMed  CAS  Google Scholar 

  20. Salk JE, Menke WJ, Francis T Jr (1945) A clinical, epidemiological and immunological evaluation of vaccination against epidemic influenza. Am J Hyg 42: 57–93

    Google Scholar 

  21. Gregg MB (1974) Recent advances in influenza vaccines. J Med 16: 651–653

    CAS  Google Scholar 

  22. Cate TR, Couch RB, Parker D, Baxter B (1983) Ractogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines-1978. Rev Infect Dis 5: 737–747

    PubMed  CAS  Google Scholar 

  23. Spila-Alegiani S, Salmaso S, Rota MC, Tozzi A, Raschetti R, the Italian SVEVA group (1999) Reactogenicity in the elderly of nine commercial influenza vaccines: Results from the Italian SVEVA study. Vaccine 17: 1898–1904

    Article  PubMed  CAS  Google Scholar 

  24. Kendal AP, Goldfield M, Noble GR, Dowdle WR (1977) Identification and preliminary antigenic analysis of swine influenza-like viruses isolated during an influenza outbreak at Fort Dix, New Jersey. J Infect Dis 136 (Suppl): S381–S385

    PubMed  Google Scholar 

  25. Goldfield M, Bartley JD, Pizzuti W, Black HC, Altman R, Halperin WE (1977) Influenza in New Jersey in 1976: Isolation of influenza A/New Jersey/76 virus at Fort Dix. J Infect Dis 136 (Suppl): S347–S355

    PubMed  Google Scholar 

  26. Top FH, Russell PK (1977) Swine influenza A at Fort Dix, New Jersey (January-February 1976). IV. Summary and speculation. J Infect Dis 136 (Suppl): S376–S380

    PubMed  Google Scholar 

  27. Gaydos JC, Top FH, Hodder RA, Russer PK (2006) Swine influenza A outbreak, Fort Dix, New Jersey, 1976. Emerg Infect Dis 12: 23–28

    PubMed  Google Scholar 

  28. Langmuir AD (1979) Guillain-Barrè syndrome: The swine influenza virus vaccine incident in the United States of America, 1976-1977; preliminary communication. J R Soc Med 72: 660–669

    PubMed  CAS  Google Scholar 

  29. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF, Eddins DL, Bryan JA (1979) Guillain-Barrè syndrome following vaccination in the national influenza immunization program, United States, 1976–1977. Am J Epidemiol 110: 105–123

    PubMed  CAS  Google Scholar 

  30. Langmuir AD, Bregman DJ, Kurland LT, Nathanson N, Victor M (1984) An epidemiologic and clinical evaluation of Guillain-Barrè syndrome reported in association with the administration of swine influenza vaccines. Am J Epidemiol 119: 841–879

    PubMed  CAS  Google Scholar 

  31. Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D, Clark S, Haber P, Stolley PD, Schonberger LB, Chen RT (1998) The Guillain-Barrè syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 339: 1797–1802

    Article  PubMed  CAS  Google Scholar 

  32. Haber P, De Stefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, Chen RT (2004) Guillain-Barrè syndrome following influenza vaccination. JAMA 292: 2478–81

    Article  PubMed  CAS  Google Scholar 

  33. Salk JE (1953) Use of adjuvants in studies on influenza immunization. 3. Degree of persistence of antibody in human subjects two years after vaccination. JAMA 151: 1169–1175

    Google Scholar 

  34. Salk JE, Bailey ML, Laurel AM (1952) The use of adjuvants in studies on influenza immunization. II. Increased antibody formation in human subjects inoculated with influenza virus vaccine in a water-in-oil emulsion. Am J Hyg 55: 439–456

    PubMed  CAS  Google Scholar 

  35. Davenport FM (1968) Seventeen years’ experience with mineral oil adjuvant influenza virus vaccines. Ann Allergy 26: 288–292

    PubMed  CAS  Google Scholar 

  36. Beebe GW, Simon AH, Vivona S (1964) Follow-up study on Army personnel who received adjuvant influenza virus vaccine 1951-1953. Am J Med Sci 247: 385–405

    Article  PubMed  CAS  Google Scholar 

  37. Beebe GW, Simon AH, Vivona S (1972) Long-term mortality follow-up of Army recruits who received adjuvant influenza virus vaccine in 1951-1953. Am J Epidemiol 95: 337–346

    PubMed  CAS  Google Scholar 

  38. Hennessy AV, Davenport FM (1961) Relative merits of aqueous and adjuvant influenza vaccines when used in a two-dose schedule. Public Health Rep 76: 411–419

    PubMed  CAS  Google Scholar 

  39. Davenport FM, Hennessy AV, Bell JA (1962) Immunologic advantages of emulsified influenza virus vaccines. Mil Med 127: 95–100

    PubMed  CAS  Google Scholar 

  40. Davis DJ, Philip RN, Bell JA, Voegel JE, Jensen DV (1961) Epidemiological studies on influenza in familiar and general population groups. 1951-1956. III. Laboratory observations. Am J Hyg 73: 138–147

    PubMed  CAS  Google Scholar 

  41. Stuart-Harris CH (1967) Scientific Publication No. 147, PAIIO, 573

    Google Scholar 

  42. Davenport FM (1968) Antigenic enhancement of ether-extracted influenza virus vaccines by AIPO4. Proc Soc Exp Biol Med 127: 587–590

    PubMed  CAS  Google Scholar 

  43. Davenport FM, Hennessy AV, Askin FB (1968) Lack of adjuvant effect of AlPO4 on purified influenza virus hemagglutinins in man. J Immunol 100: 1139–1140

    PubMed  CAS  Google Scholar 

  44. Werner J, Kuwert EK, Stegmaier R, Simbock H (1980) [Local and systemic antibody response after vaccination with 3 different types of vaccines against influenza. II. Neuraminidase inhibiting antibodies (author’s transl)]. Zentralbl Bakteriol A 246: 1–9

    PubMed  CAS  Google Scholar 

  45. D’Errico MM, Grasso GM, Romano F, Montanaro D (1988) [Comparison of anti-influenza vaccines: Whole adsorbed trivalent, trivalent subunit and tetravalent subunit]. Boll Ist Sieroter Milan 67: 283–289

    PubMed  CAS  Google Scholar 

  46. Ionita E, Lupulescu E, Alexandrescu V, Matepiuc M, Constantinescu C, Cretescu L et al (1989) Comparative study of the immunogenicity of aqueous versus aluminium phosphate adsorbed split influenza vaccine C.I. Arch Roum Pathol Exp Microbiol 48: 265–273

    PubMed  CAS  Google Scholar 

  47. Van Nest GA, Steimer KS, Haigwood NL, Burke RL, Ott G (1992) Advanced adjuvant formulations for use with recombinant subunit vaccines. In: F Brown, RM Chanock, HS Ginsberg, RA Lerner (eds): Vaccines 92. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 57–62

    Google Scholar 

  48. Baylor NW, Egan W, Richman P (2002) Aluminum salts in vaccines-US perspective. Vaccine 20: S18–S23

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Novartis Vaccines and Diagnostics, Via Fiorentina 1, 53100, Siena, Italy

    Maria Lattanzi

Authors
  1. Maria Lattanzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Novartis Vaccines, Via Fiorentina 1, 53100, Siena, Italy

    Rino Rappuoli  & Giuseppe Del Giudice  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Birkhäuser Verlag Basel/Switzerland

About this chapter

Cite this chapter

Lattanzi, M. (2008). Non-recent history of influenza pandemics, vaccines, and adjuvants. In: Rappuoli, R., Del Giudice, G. (eds) Influenza Vaccines for the Future. Birkhäuser Advances in Infectious Diseases. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-8371-8_11

Download citation

Publish with us

Policies and ethics

Search

Navigation